INDSWFTLAB Charts, Analysis and Tips

home > pharma-and-healthcare > pharmaceuticals > indswftlab

Technical Analysis

Technical Strength: 3 / 10
Indicator Analysis Signal (0 - 10) Chart
RSI (?) RSI is 48.4. According to RSI analysis, indswftlab is marginally weak. 4.0 INDSWFTLAB RSI Chart
MACD (?) MACD: 0.23 and Signal Line: 0.269. According to MACD analysis, a bearish crossover just happend and it's a negative signal. 0.0 INDSWFTLAB MACD Chart
Simple Moving Average (?) Price just got below it's 20-day simple moving average which is a negative signal. According to simple moving average analysis, indswftlab is facing resistance at 62.1 and support level is at 44.7355. 2.0 INDSWFTLAB Simple Moving Average Chart
Exponential Moving Average (?) Price just got below it's 20-day exponential moving average which is a negative signal. According to exponential moving average analysis, indswftlab is facing resistance from it's 20-day exponential moving average at 62.28999 and support level is at 60.8. 2.0 INDSWFTLAB Exponential Moving Average Chart
Bollinger Bands (?) %b is 0.451. 5.0 INDSWFTLAB Bollinger Bands Chart
Fibonacci Retracement (?) According to fibonacci retracement, price is above 61.8% and 50% level. Support is at 61.675 and 59.9463. Resistance level is 63.4037. 8.0 INDSWFTLAB Fibonacci Retracement Chart
Average True Range (?) ATR: 3.16 NA INDSWFTLAB Average True Range Chart
Average Directional Index (?) ADX is 21.8 which means INDSWFTLAB is in a trading range and there is no trend. NA INDSWFTLAB Average Directional Index Chart
Note: Technical Analysis updated at 7PM on every trading day.
End-of-Day Share Price - NSE
April 26, 2018
Open Price 62.75
High Price 63.85
Low Price 61.5
Close Price 61.7
Absolute Change -1.5
Percentage Change -2.37%
Weekly Change -0.081%
Monthly Change 5.38%
Yearly Change 67.4%
52-week high 83.9
52-week low 31.25
Corporate Actions
ExDate Purpose
September 14, 2017 ANNUAL GENERAL MEETING
September 18, 2014 Annual General Meeting
September 20, 2011 AGM/DIV-RE.1/- PER SHARE
See all Corporate Actions
Volume Chart
Real time prices can be delayed by 20 minutes. Prices are refreshed from our server automatically after 1 minute. If NSE real time price is not available then BSE real time prices are provided. Volume displayed might not be correct..

Fundamental Analysis

Beta (?)1.14
Confidence in Beta2.69%
Market Capital Rs. 252.0 Cr
Diluted Trailing Twelve Months (TTM) Earnings Per Share (EPS) Rs. -14.37
TTM Price-to-Earnings (P/E) Ratio -4.29
Whenever available, consolidated financial results are used. For details, see here.
Stock Deliverable Quantity and Daily Volatility
Indicator Analysis Signal (0 - Strong Sell, 10 - Strong Buy) Chart
Deliverable Quantity (?) 26 April 2018: Deliverable Quantity:2.12e+04 NA INDSWFTLAB Deliverable Quantity Chart
Annualized Daily Volatility (Spot Price) (?) 26 April 2018: Daily Volatility:0.47 NA INDSWFTLAB Annualized Daily Volatility (Spot Price) Chart

Announcements

April 11, 2018 Disc. under Reg.30 of SEBI (SAST) Reg.2011 For and on behalf of Promoter & Promoters group has submitted to the Exchange a copy of disclosure under Regulation 30(1) and 30(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.
April 02, 2018 Shareholders meeting Ind-Swift Laboratories Limited has informed the Exchange regarding Proceedings of Extraordinary General Meeting held on March 28, 2018
See all Announcements

Board Meetings

Date Meeting Date Purpose
February 12, 2018 February 13, 2018 Results/Others The Company had informed the Exchange regarding the meeting of the Board of Directors of the Company scheduled to be held on February 13, 2018 To consider inter-alia among other items, the Un-audited Financial Results for the quarter ended December 31, 2017. The Company has now informed the Exchange that the Board will also consider the matter relating to raising of funds through Preferential Issue of Equity shares/ Convertible Warrants to persons/entities other than Promoters.(Purpose Revised).
January 30, 2018 February 13, 2018 Results/Others To consider inter-alia among other items, the Un-audited Financial Results for the quarter ended December 31, 2017.
See all Board Meetings

Intraday Pivot Points

S3 S2 S1 Pivot R1 R2 R3
Rs. 58.5 Rs. 60 Rs. 60.85 Rs. 62.35 Rs. 63.2 Rs. 64.7 Rs. 65.55